• N/A
    Market Cap
  • -92.92%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
49,894
+3.26%
48,321
N/A
Cost of Revenue
50,539
-1.57%
51,345
N/A
Gross Profit
-645
-78.67%
-3,024
N/A
Sales and Marketing Expense
4.6M
+228.53%
1.4M
N/A
Research and Development Expense
-226,884
-6.00%
-241,362
N/A
Depreciation and Amortization Expense
36,523
-13.42%
42,185
N/A
Total Operating Expenses
4.8M
+194.06%
1.6M
N/A
Operating Profit
-4.8M
+193.56%
-1.6M
N/A
Interest Income
26,562
N/A
N/A
N/A
Interest Expense
-14,724
-60.43%
-37,210
N/A
Interest Income and Expense and Net
11,838
+131.81%
-37,210
N/A
Total Nonoperating Income and Expense
219,731
+60.79%
136,655
N/A
Income before Taxes
-4.6M
+205.59%
-1.5M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-4.3M
+176.70%
-1.6M
N/A
Net Income from Continuing Operations Applicable to Common
-4.6M
+205.59%
-1.5M
N/A
Basic EPS and Net Income
-22.83
+163.02%
-8.68
N/A
Diluted EPS and Net Income
-22.83
+163.02%
-8.68
N/A
Basic Weighted Average Shares
20.5M
+13.73%
18.0M
N/A
Diluted Weighted Average Shares
20.5M
+13.73%
18.0M
N/A
Balance Sheet
Cash and Cash Equivalents
3.1M
+2,576.77%
116,472
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.1M
+2,576.77%
116,472
N/A
Total Current Assets
7.3M
+4,916.13%
146,152
N/A
Accumulated Depreciation
185,718
+24.48%
149,195
N/A
Property and Plant and Equipment and Net
77,525
+33.51%
58,065
N/A
Total Long-Term Assets
1.2M
+1,218.38%
89,005
N/A
Total Assets
8.5M
+387.36%
1.7M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
38,728
-29.90%
55,250
N/A
Total Current Liabilities
3.1M
-44.62%
5.6M
N/A
Total Long-Term Debt
126,201
-22.92%
163,728
N/A
Total Long-Term Liabilities
333,758
+103.85%
163,728
N/A
Total Liabilities
3.4M
-44.41%
6.2M
N/A
Retained Earnings
-9.2M
+102.46%
-4.6M
N/A
Total Stockholders Equity
5.1M
+213.36%
-4.5M
N/A
Total Shares Outstanding
7.4M
+88.12%
3.9M
N/A
Cash Flow
Cash from Operating Activities
-9.1M
+639.00%
-1.2M
N/A
Capital Expenditures
58,229
+166.08%
21,884
N/A
Cash from Investing Activities
-58,229
+166.08%
-21,884
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
12.2M
+812.15%
1.3M
N/A
Financials Ratio
Gross Margin
-1.29%
N/A
N/A
N/A
Operating Margin
-9,680.18%
N/A
N/A
N/A
Return on Assets
-84.36%
N/A
N/A
N/A
Return on Equity
-1,451.50%
N/A
N/A
N/A
Revenue Growth
3.26%
N/A
N/A
N/A
Current Ratio
2.35
N/A
N/A
N/A
Cash Ratio
1.00
N/A
N/A
N/A
Debt-to-Equity Ratio
0.03
N/A
N/A
N/A
Debt-to-Assets Ratio
0.02
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow